|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2005-11-21
|
|
pubmed:abstractText |
The viral diversity of HIV-1 is likely to require a vaccine strategy that induces broad cellular and humoral anti-HIV-1 immunity. Our strategy is based on multiple HIV-1 DNA immunogens together with adjuvant recombinant granulocyte-macrophage stimulating factor. This article describes pre-clinical and clinical work preceding the initiation of clinical HIV-1 phase I/II trials.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/AIDS Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, gag,
http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, nef,
http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, rev,
http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, tat,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Envelope Protein gp160,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Reverse Transcriptase,
http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, Combined,
http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, DNA,
http://linkedlifedata.com/resource/pubmed/chemical/nef Gene Products, Human...,
http://linkedlifedata.com/resource/pubmed/chemical/rev Gene Products, Human...,
http://linkedlifedata.com/resource/pubmed/chemical/tat Gene Products, Human...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1286-4579
|
|
pubmed:author |
pubmed-author:BlombergPP,
pubmed-author:BobergAA,
pubmed-author:BråveAA,
pubmed-author:EngströmGG,
pubmed-author:GudmundsdotterLL,
pubmed-author:HejdemanBB,
pubmed-author:HinkulaJJ,
pubmed-author:IsaguliantsMM,
pubmed-author:LinDD,
pubmed-author:LjungbergKK,
pubmed-author:LundgrenBB,
pubmed-author:RollmanEE,
pubmed-author:SandströmEE,
pubmed-author:WahrenBB
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1414-23
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16257558-AIDS Vaccines,
pubmed-meshheading:16257558-Animals,
pubmed-meshheading:16257558-Clinical Trials, Phase I as Topic,
pubmed-meshheading:16257558-Clinical Trials, Phase II as Topic,
pubmed-meshheading:16257558-Disease Models, Animal,
pubmed-meshheading:16257558-Gene Products, gag,
pubmed-meshheading:16257558-Gene Products, nef,
pubmed-meshheading:16257558-Gene Products, rev,
pubmed-meshheading:16257558-Gene Products, tat,
pubmed-meshheading:16257558-HIV Antigens,
pubmed-meshheading:16257558-HIV Envelope Protein gp160,
pubmed-meshheading:16257558-HIV Infections,
pubmed-meshheading:16257558-HIV Reverse Transcriptase,
pubmed-meshheading:16257558-HIV-1,
pubmed-meshheading:16257558-Humans,
pubmed-meshheading:16257558-Leukemia Virus, Murine,
pubmed-meshheading:16257558-Mice,
pubmed-meshheading:16257558-Mice, Inbred C57BL,
pubmed-meshheading:16257558-Vaccines, Combined,
pubmed-meshheading:16257558-Vaccines, DNA,
pubmed-meshheading:16257558-nef Gene Products, Human Immunodeficiency Virus,
pubmed-meshheading:16257558-rev Gene Products, Human Immunodeficiency Virus,
pubmed-meshheading:16257558-tat Gene Products, Human Immunodeficiency Virus
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
The rationale behind a vaccine based on multiple HIV antigens.
|
|
pubmed:affiliation |
Swedish Institute for Infectious Disease Control, Solna, Sweden.
|
|
pubmed:publicationType |
Journal Article
|
